Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850758 · ClinicalTrials.gov registry record · NA
Regenexx™ SD Versus Exercise Therapy for ACL Tears
A NA study of Anterior Cruciate Ligament Tear, sponsored by Regenexx.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01850758 is a NA study of Anterior Cruciate Ligament Tear that has completed, run by Regenexx. The registered enrollment target is 50 participants, below the 226-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01850758, a NA study of Anterior Cruciate Ligament Tear, has completed, sponsored by Regenexx.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the improvement in subject-reported clinical outcomes for Regenexx SD vs. Exercise Therapy treatment of partial and complete, non-retracted knee ACL ligament tears, from baseline to 3 months, with continued evaluation of efficacy and durability up to 24 months. Secondary objectives include evaluation of MRI evidence of tendon repair; incidence of post-operative complications, adverse events, re-injections, and surgical intervention; change in pain score and use of pain medications.
Conditions Studied
Interventions
- PROCEDURE Regenexx SD
- OTHER Exercise Therapy
Study Locations (1)
Colorado
- Centeno-Schultz Clinic - Broomfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-05 |
| Est. Completion | 2022-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01850758
The ClinicalTrials.gov registry entry for NCT01850758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (78% lower). The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 2 interventions - of which Regenexx SD is the first listed.
NCT01850758 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01850758 about?
NCT01850758 is a clinical study titled "Regenexx™ SD Versus Exercise Therapy for ACL Tears". The primary objective of this study is to compare the improvement in subject-reported clinical outcomes for Regenexx SD vs. Exercise Therapy treatment of partial and complete, non-retracted knee ACL ligament tears, from baseline to 3 months, with continued evaluation of efficacy and durability up to...
What is the current status of trial NCT01850758?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2022-03-08.
What conditions does trial NCT01850758 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear.
What interventions are being tested in trial NCT01850758?
The interventions under investigation include: Regenexx SD (PROCEDURE), Exercise Therapy (OTHER).
Who is sponsoring clinical trial NCT01850758?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01850758 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)
ACTIVE NOT RECRUITING · NA
-
Bridge-Enhanced ACL Repair vs ACL Reconstruction
ACTIVE NOT RECRUITING · NA
-
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
ACTIVE NOT RECRUITING · NA
-
Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial
ACTIVE NOT RECRUITING · NA
-
A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction
ACTIVE NOT RECRUITING · NA
-
Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following ACL Surgery
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.